The liver is the largest internal organ in the body and hepatic function is crucial to good health. A variety of analytes are designated as routine markers of liver disease. When used together in panels or individually, they can help detect and monitor hepatic disease.
For in vitro diagnostics use only.
Abbott liver function assays are designed to help evaluate liver health. Albumin is the major blood protein and is produced by the liver. Two dye binding assays, BCG and BCP, are used to measure albumin, which is decreased or increased in various diseases. The common liver enzymes ALT and AST are important markers for conditions such as hepatitis.
Hepatic malfunction is indicated by abnormal levels of direct and total bilirubin. Ammonia is a marker of acute liver failure and the enzyme GGT is associated with alcohol abuse and liver cirrhosis. Bile acids produced by the liver are necessary to lipid metabolism. All of these can be used to narrow and accurately assess disease states and treatment options.
| Hepatitis |
|---|
| Anti-HAV IgG |
| Anti-HAV IgM |
| Anti-HBc IgM |
| Anti-HBe |
| Anti-HBs |
| Anti-HCV |
| HBeAg |
| HBsAg (Qualitative Conf.) |
| HBsAg (Quantitative) |
| HCV Ag |
| Liver Disease |
|---|
| Albumin (BCG) |
| Albumin (BCP) |
| Alkaline Phosphatase |
| Alpha-1 Antitrypsin |
| ALT (Alanine Aminotransferase) |
| ALT, Activated (Alanine Aminotransferase) |
| Ammonia |
| AST (Aspartate Aminotransferase) |
| AST, Activated (Aspartate Aminotransferase) |
| Bile Acids |
| Cholinesterase |
| Cholinesterase/Dibucain |
| Direct Bilirubin |
| GGT (Gamma-Glutamyl Transferase) |
| Lactate Dehydrogenase (LD) |
| PIVKA-II |
| Total Bilirubin |
Diagnostics at Abbott offers a complete portfolio of integrated solutions including Core Laboratory, Molecular, Point of Care, Rapid Diagnostics and Transfusion Medicine.
Abbott scientists and market experts are continuously working together to solve today's challenges, understand future needs and eliminate gaps in the diagnosis of hepatitis infected patients and in our overall health care community. Abbott continues to research and invest in expanding hepatitis-testing options to a variety of diagnostic platforms.
Find the latest information in laboratory science, therapeutic areas and Abbott innovation.
Learn how Abbott has helped physicians evaluate suspected mild traumatic brain injury (mTBI).
Discover how Alinity uses technology to redefine and improve operational productivity and confidence in your laboratory.
Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott. The website that you have requested also may not be optimised for your screen size.
Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.
